Sanger Leadership Team

The Sanger Leadership Team is an Executive Committee that reports to the Director and the Genome Research Limited (GRL) Board. It is designed to enable holistic and effective decision making, with transparency and accountability woven into its make up. The Committee is made up of senior leaders that are tasked with making significant and sound decisions in the best interest of Sanger as it supports and delivers its scientific mission and positively influences Sanger’s organisational culture with a focus on equality, diversity and inclusion.

Membership

Chair

Wellcome Sanger Institute Director

Professor Matthew Hurles

Members

Director of Strategy, Policy and Innovation

Dr Julia Wilson

 

Interim Director of Connecting Science

Dr Ireena Dutta

 

Head of the Cellular Genomics Programme and Deputy Director

Professor Muzlifah Haniffa

 

Head of the Generative and Synthetic Genomics Programme

Professor Ben Lehner

 

Head of the Tree of Life Programme

Professor Mark Blaxter

 

Interim Head of the Somatic Genomics Programme

Dr David Adams

 

Head of the Human Genetics Programme

Dr Carl Anderson

 

Head of the Parasites and Microbes Programme

Professor Nicholas Thomson

 

 

Chief Operating Officer

Simon Moore

 

 

Chief Financial Officer

Anna Marchent

 

Standing Attendees

 

 

Secretariat: Executive Assistant to Wellcome Sanger Institute Director

Katharine Sparrow

Chief of Staff to Sanger Director

Carl Logan

General Counsel and Company Secretary

Nadia Meliti

 

Director of Human Resources

Danielle Norby

Observer

Wellcome Representative

Matt Kaiser

Related Sanger Institute Governance